ASX:DRUG

BetaShares Global Healthcare ETF - Currency Hedged Stock Forecast, Price & News

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive DRUG News and Ratings via Email

Sign-up to receive the latest news and ratings for BetaShares Global Healthcare ETF - Currency Hedged and its competitors with MarketBeat's FREE daily newsletter.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: ASX:DRUG
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for BetaShares Global Healthcare ETF - Currency Hedged.

0.0 Community Rank

Outperform Votes
BetaShares Global Healthcare ETF - Currency Hedged has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
BetaShares Global Healthcare ETF - Currency Hedged has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about BetaShares Global Healthcare ETF - Currency Hedged and other stocks. Vote “Outperform” if you believe DRUG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DRUG will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
BetaShares Global Healthcare ETF - Currency Hedged does not currently pay a dividend.
Dividend Growth
BetaShares Global Healthcare ETF - Currency Hedged does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BetaShares Global Healthcare ETF - Currency Hedged insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

BetaShares Global Healthcare ETF - Currency Hedged (ASX:DRUG) Frequently Asked Questions

What stocks does MarketBeat like better than BetaShares Global Healthcare ETF - Currency Hedged?: Wall Street analysts have given BetaShares Global Healthcare ETF - Currency Hedged a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BetaShares Global Healthcare ETF - Currency Hedged wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
How often does BetaShares Global Healthcare ETF - Currency Hedged pay dividends? What is the dividend yield for BetaShares Global Healthcare ETF - Currency Hedged?: BetaShares Global Healthcare ETF - Currency Hedged announced a Interim dividend on Monday, January 4th. Shareholders of record on Tuesday, January 19th will be paid a dividend of 0.017 per share on Tuesday, January 19th. This represents a yield of 0.24%. The ex-dividend date is Monday, January 4th.
View BetaShares Global Healthcare ETF - Currency Hedged's dividend history.
What is BetaShares Global Healthcare ETF - Currency Hedged's stock symbol?: BetaShares Global Healthcare ETF - Currency Hedged trades on the ASX under the ticker symbol "DRUG."

This page was last updated on 10/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.